GlobalData predicts that six late-stage pipeline products are set to enter the glaucoma market during the forecast period.

Eyelash serums claim to give you longer, thicker lashes, but before you dive in, discover the science and safety behind these products.

Bimatoprost is under clinical development by Laboratoires Thea and currently in Phase III for Ocular Hypertension. According to GlobalData, Phase III drugs for Ocular Hypertension have a 75% phase ...

NCX 470 is a novel nitric oxide (NO)-donating bimatoprost eye drop that leverages the potent IOP lowering effects of NO and prostaglandin analogs (PGAs). NCX 470 incorporates Nicox’s proprietary ...

Topical ocular PG agonists have been developed for two purposes: to treat elevated IOP and slow the progression of glaucoma and to increase eyelash growth for cosmetic effect. NSAIDs (Inhibit COX ...